Alzchem Group AG (XTER:ACT) Total Stockholders Equity: €274.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:ACT Alzchem Group AG XTER:ACT
60 GF Score
Price €174.20
! 4 Warning Signs
View Full Analysis

What is Alzchem Group AG Total Stockholders Equity?

Alzchem Group AG XTER:ACT +0.29% 60 Total Stockholders Equity is €274.1 Mil as of Mar. 2026. GuruFocus rates XTER:ACT with a GF Score™ of 60/100. The stock has 4 warning signs investors should review.

Alzchem Group AG's Total Stockholders Equity for the quarter that ended in Mar. 2026 was €274.1 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Alzchem Group AG's Book Value per Share for the quarter that ended in Mar. 2026 was €27.08. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Alzchem Group AG's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.00.


Alzchem Group AG  (XTER:ACT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Alzchem Group AG's Book Value per Share for the quarter that ended in Mar. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Alzchem Group AG's Debt-to-Equity for the quarter that ended in Mar. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alzchem Group AG Total Stockholders Equity Related Terms


Alzchem Group AG Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Alzchem Group AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzchem Group AG Total Stockholders Equity Chart

Alzchem Group AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.63 144.01 161.63 205.54 256.30

Alzchem Group AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 220.97 217.30 233.71 256.30 274.13
XTER:ACT
60GF Score
Alzchem Group AG XTER:ACT
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €274.1 Mil mean?
Alzchem Group AG (XTER:ACT) has a Total Stockholders Equity of €274.1 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Alzchem Group AG and its competitors.
Is Alzchem Group AG's Total Stockholders Equity too high?
Alzchem Group AG's current Total Stockholders Equity is €274.1 Mil. Overall, Alzchem Group AG has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's Total Stockholders Equity compare to LIN and SHW?
Alzchem Group AG's Total Stockholders Equity of €274.1 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Chemicals company?
A good Total Stockholders Equity depends on the Chemicals industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Alzchem Group AG and its competitors. Alzchem Group AG's current Total Stockholders Equity is €274.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Alzchem Group AG (XTER:ACT) has a current Total Stockholders Equity of €274.1 Mil. The current Total Stockholders Equity is €274.1 Mil. Alzchem Group AG's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Alzchem Group AG (XTER:ACT), the current Total Stockholders Equity is €274.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alzchem Group AG Business Description

Address Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
60GF Score

Get the complete analysis for XTER:ACT

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€174.20
Price